Literature DB >> 16541136

Marek's disease virus: from miasma to model.

Nikolaus Osterrieder1, Jeremy P Kamil, Daniel Schumacher, B Karsten Tischer, Sascha Trapp.   

Abstract

Marek's disease virus (MDV) is an oncogenic herpesvirus that causes various clinical syndromes in its natural host, the chicken. MDV has long been of interest as a model organism, particularly with respect to the pathogenesis and immune control of virus-induced lymphoma in an easily accessible small-animal system. Recent advances in MDV genetics and the determination of the chicken genome sequence, aided by functional genomics, have begun to dramatically increase our understanding not only of lytic MDV replication, but also of the factors and mechanisms leading to latency and tumour formation. This new information is helping to elucidate cellular signalling pathways that have undergone convergent evolution and are perturbed by different viruses, and emphasizes the value of MDV as a comparative biomedical model. Furthermore, the door is now open for rational and efficient engineering of new vaccines against one of the most important and widespread infectious diseases in chickens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16541136     DOI: 10.1038/nrmicro1382

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  150 in total

1.  The ORF012 gene of Marek's disease virus type 1 produces a spliced transcript and encodes a novel nuclear phosphoprotein essential for virus growth.

Authors:  Timo Schippers; Keith Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  A novel herpesvirus in 3 species of pheasants: mountain peacock pheasant (Polyplectron inopinatum), Malayan peacock pheasant (Polyplectron malacense), and Congo peafowl (Afropavo congensis).

Authors:  T A Seimon; D McAloose; B Raphael; K S Honkavuori; T Chang; D L Hirschberg; W I Lipkin
Journal:  Vet Pathol       Date:  2011-11-10       Impact factor: 2.221

3.  Neurotropic T-cell-rich B-cell lymphoma in a 14-year-old Morgan gelding.

Authors:  Trina L Westerman; Keith P Poulsen; John W Schlipf; Beth A Valentine
Journal:  Can Vet J       Date:  2014-04       Impact factor: 1.008

4.  Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

5.  Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek's disease virus.

Authors:  Stephen J Spatz; Yuguang Zhao; Lawrence Petherbridge; Lorraine P Smith; Susan J Baigent; Venugopal Nair
Journal:  Virus Genes       Date:  2007-08-25       Impact factor: 2.332

6.  Marek's disease virus may interfere with T cell immunity by TLR3 signals.

Authors:  Xuming Hu; Wencai Xu; Aijian Qin; Genghua Wu; Kun Qian; Hongxia Shao; Jianqiang Ye
Journal:  Vet Res Commun       Date:  2014-03-02       Impact factor: 2.459

7.  Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles.

Authors:  Johnathan Storlie; John E Carpenter; Wallen Jackson; Charles Grose
Journal:  Virology       Date:  2008-10-26       Impact factor: 3.616

8.  Viral control of vTR expression is critical for efficient formation and dissemination of lymphoma induced by Marek's disease virus (MDV).

Authors:  Najat Chbab; Annemarie Egerer; Inês Veiga; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  Vet Res       Date:  2010-04-29       Impact factor: 3.683

9.  Mapping QTL affecting resistance to Marek's disease in an F6 advanced intercross population of commercial layer chickens.

Authors:  Eliyahu M Heifetz; Janet E Fulton; Neil P O'Sullivan; James A Arthur; Hans Cheng; Jing Wang; Morris Soller; Jack C M Dekkers
Journal:  BMC Genomics       Date:  2009-01-14       Impact factor: 3.969

10.  Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans.

Authors:  Sophie R Bader; Sonja Kothlow; Sascha Trapp; Susanne Cn Schwarz; Hans-Christian Philipp; Steffen Weigend; Ahmad R Sharifi; Rudolf Preisinger; Wolfgang Schmahl; Bernd Kaspers; Kaspar Matiasek
Journal:  J Neuroinflammation       Date:  2010-01-28       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.